LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Dewhurst, E.; Novakova, B.; Reuber, M. (2015)
Publisher: Elsevier
Languages: English
Types: Article
Subjects:
Objective: The aims of this service evaluation were to explore the effectiveness of a psychotherapeutic treatment for patients with epilepsy based on the acceptance and commitment therapy (ACT) approach and to assess whether this treatment is likely to be cost-effective. \ud \ud Method: We conducted an uncontrolled prospective study of consecutive patients with refractory epilepsy referred for outpatient psychological treatment to a single psychotherapist because of emotional difficulties related to their seizure disorder. Participants were referred by consultant neurologists, neuropsychologists, or epilepsy nurses, completed a set of validated self-report questionnaires (Short Form - 12 version 2, Generalized Anxiety Disorder - 7, Neurological Disorders Depression Inventory for Epilepsy, Work and Social Adjustment Scale, and Rosenberg Self-Esteem Scale), and reported their seizure frequency at referral, the end of therapy, and six months posttherapy. Patients received a maximum of 20 sessions of one-to-one psychological treatment supported by a workbook. Cost-effectiveness was estimated based on the calculation of quality-adjusted life year (QALY) gains associated with the intervention. \ud \ud Results: Sixty patients completed the prepsychotherapy and postpsychotherapy questionnaires, among whom 41 also provided six-month follow-up data. Patients received six to 20 sessions of psychotherapy (mean = 11.5, S.D. = 9.6). Psychotherapy was associated with significant medium to large positive effects on depression, anxiety, quality of life, self-esteem, and work and social adjustment ( ps < .001), which were sustained six months after therapy. The mean cost of the psychotherapy was £445.6, and, assuming that benefits were maintained for at least six months after the end of therapy, the cost per QALY was estimated to be £11,140 (€14,119, $18,016; the cost per QALY would be half this amount if the benefits lasted one year). \ud \ud Conclusion: The findings of this pilot study indicate that the described psychotherapeutic intervention may be a cost-effective treatment for patients with epilepsy. The results suggest that a randomized controlled trial of the psychotherapy program is justified.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [1] Tellez-Zenteno, J.F., Patten, S.B., Jette, N., Williams, J. and Wiebe, S. Psychiatric comorbidity in epilepsy: A population-based analysis. Epilepsia 2007; 48:2336-2344.
    • [2] Fisher, R.S., Vickrey, B.G., Gibson, P., Hermann, B., Penovich, P., Scherer, A. and Walker, S. The impact of epilepsy from the patient's perspective I. Descriptions and subjective perceptions. Epilepsy Res 2000; 41:39-51.
    • [3] Lu, B. and Elliott, J.O. Beyond seizures and medications: Normal activity limitations, social support, and mental health in epilepsy. Epilepsia 2012; 53:e25-e28.
    • [4] Baker, G.A., Jacoby, A., Buck, D., Stalgis, C. and Monnet, D. Quality of life of people with epilepsy: A European study. Epilepsia 1997; 38:353-362.
    • [5] Baker, G.A., Brooks, J., Buck, D. and Jacoby, A. The stigma of epilepsy: A European perspective. Epilepsia 2000; 41:98-104.
    • [6] Jacoby, A. Epilepsy and stigma: An update and critical review. Current Neurology and Neuroscience Reports 2008; 8:339-344.
    • [7] NICE The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. In: National Institute for Health and Clinical Excellence clinical guideline 137, 2012.
    • [8] Goldstein, L.H. Effectiveness of psychological interventions for people with poorly controlled epilepsy. Journal of Neurology Neurosurgery and Psychiatry 1997; 63:137-142.
    • [9] Mittan, R.J. Psychosocial treatment programs in epilepsy: A review. Epilepsy & Behavior 2009; 16:371-380.
    • [10] Tang, V., Michaelis, R. and Kwan, P. Psychobehavioral therapy for epilepsy. Epilepsy & Behavior 2014; 32:147-155.
    • [11] Ramaratnam, S., Baker, G.A. and Goldstein, L.H. Psychological treatments for epilepsy. Cochrane Database of Systematic Reviews 2008; 37.
    • [12] Hayes, S.C. and Strosahl, K.D. A Practical Guide to Acceptance and Commitment Therapy Springer Science & Business Media, Inc., 2010.
    • [13] Dewhurst, E. and Reuber, M. Understanding Epilepsy A Psychotherapeutic Approach, Unpublished Brochure.
    • [14] Ware, J.E., Kosinski, M. and Keller, S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 1996; 34:220 - 233.
    • [15] Lam, E.T.P., Lam, C.L.K., Fong, D.Y.T. and Huang, W.W. Is the SF-12 version 2 Health Survey a valid and equivalent substitute for the SF-36 version 2 Health Survey for the Chinese? Journal of Evaluation in Clinical Practice 2013; 19:200-208.
    • [16] Cheak-Zamora, N.C., Wyrwich, K.W. and McBride, T.D. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Quality of Life Research 2009; 18:727-735.
    • [17] Spitzer, R.L., Kroenke, K., Williams, J.B.W. and Lowe, B. A brief measure for assessing generalized anxiety disorder - The GAD-7. Archives of Internal Medicine 2006; 166:1092-1097.
    • [18] Lowe, B., Decker, O., Muller, S., Brahler, E., Schellberg, D., Herzog, W. and Herzberg, P.Y. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care 2008; 46:266-274.
    • [19] Dear, B.F., Titov, N., Sunderland, M., McMillan, D., Anderson, T., Lorian, C. and Robinson, E. Psychometric Comparison of the Generalized Anxiety Disorder Scale-7 and the Penn State Worry Questionnaire for Measuring Response during Treatment of Generalised Anxiety Disorder. Cognitive Behaviour Therapy 2011; 40:216-227.
    • [20] Delgadillo, J., Payne, S., Gilbody, S., Godfrey, C., Gore, S., Jessop, D. and Dale, V. Brief case finding tools for anxiety disorders: Validation of GAD-7 and GAD-2 in addictions treatment. Drug and Alcohol Dependence 2012; 125:37-42.
    • [21] Ruiz, M.A., Zamorano, E., Garcia-Campayo, J., Pardo, A., Freire, O. and Rejas, J. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. Journal of Affective Disorders 2011; 128:277-286.
    • [22] Rakesh, S.P., Ramesh, R., Rachel, P., Chanda, R., Satish, N. and Mohan, V.R. Quality of life among people with epilepsy: A cross-sectional study from rural southern India. The National medical journal of India 2012; 25:261-264.
    • [23] Gilliam, F.G., Barry, J.J., Hermann, B.P., Meador, K.J., Vahle, V. and Kanner, A.M. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurology 2006; 5:399-405.
    • [24] Margrove, K., Mensah, S., Thapar, A. and Kerr, M. Depression screening for patients with epilepsy in a primary care setting using the Patient Health Questionnaire-2 and the Neurological Disorders Depression Inventory for Epilepsy. Epilepsy & Behavior 2011; 21:387-390.
    • [25] Mundt, J.C., Marks, I.M., Shear, M.K. and Greist, J.H. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 2002; 180:461-464.
    • [26] Mataix-Cols, D., Cowley, A.J., Hankins, M., Schneider, A., Bachofen, M., Kenwright, M., Gega, L., Cameron, R. and Marks, I.M. Reliability and validity of the Work and Social Adjustment Scale in phobic disorders. Comprehensive Psychiatry 2005; 46:223-228.
    • [27] Jansson-Frojmark, M. The Work and Social Adjustment Scale as a Measure of Dysfunction in Chronic Insomnia: Reliability and Validity. Behavioural and Cognitive Psychotherapy 2014; 42:186- 198.
    • [28] Goldstein, L.H., Chalder, T., Chigwedere, C., Khondoker, M.R., Moriarty, J., Toone, B.K. and Mellers, J.D.C. Cognitive-behavioral therapy for psychogenic nonepileptic seizures A pilot RCT. Neurology 2010; 74:1986-1994.
    • [29] Chen, D.K., Maheshwari, A., Franks, R., Trolley, G.C., Robinson, J.S. and Hrachovy, R.A. Brief group psychoeducation for psychogenic nonepileptic seizures: A neurologist-initiated program in an epilepsy center. Epilepsia 2014; 55:156-166.
    • [30] Rosenberg, M. Society and the adolescent self-image, Princeton University Press, Princeton, NJ, 1965.
    • [31] Schmitt, D.P. and Allik, J. Simultaneous administration of the Rosenberg Self-Esteem Scale in 53 nations: Exploring the universal and culture-specific features of global self-esteem. Journal of Personality and Social Psychology 2005; 89:623-642.
    • [32] Hagborg, W.J. THE ROSENBERG SELF-ESTEEM SCALE AND HARTER SELF-PERCEPTION PROFILE FOR ADOLESCENTS - A CONCURRENT VALIDITY STUDY. Psychology in the Schools 1993; 30:132-136.
    • [33] Shevlin, M.E., Bunting, B.P. and Lewis, C.A. CONFIRMATORY FACTOR-ANALYSIS OF THE ROSENBERG SELF-ESTEEM SCALE. Psychological Reports 1995; 76:707-710.
    • [34] Brazier, J.E. and Roberts, J. The estimation of a preference-based measure of health from the SF-12. Medical Care 2004; 42:851-859.
    • [35] Reuber, M., Burness, C., Howlett, S., Brazier, J. and Grunewald, R. Tailored psychotherapy for patients with functional neurological symptoms: A pilot study. Journal of Psychosomatic Research 2007; 63:625-632.
    • [36] Field, A. Discovering Statistics Using SPSS, Third ed., SAGE Publications Ltd, London, 2009.
    • [37] Cohen, J. A POWER PRIMER. Psychological Bulletin 1992; 112:155-159.
    • [38] Hermann, B. and Jacoby, A. The psychosocial impact of epilepsy in adults. Epilepsy & Behavior 2009; 15:S11-S16.
    • [39] Kerr, M.P., Mensah, S., Besag, F., de Toffol, B., Ettinger, A., Kanemoto, K., Kanner, A., Kemp, S., Krishnamoorthy, E., LaFrance, W.C., Mula, M., Schmitz, B., van Elst, L.T., Trollor, J. and Wilson, S.J. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52:2133-2138.
    • Change Total 100% Improvement (seizure-free) >50% Improvement No change (A50% improvement to A50% deterioration) >50% Deterioration >100% Deterioration
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article